about
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing...
Read More
16.62
-0.22
(-1.31%)
93,196
XNAS Volume
XNAS 08 Oct, 2025 10:38 AM (EDT)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
UroGen Pharma Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..